Tag: Novavax

Browse exclusive Tags!

Novavax, Inc. Stock Rises 1.08% Despite Volatility in Healthcare Sector

Novavax, Inc. (NVAX) sees a slight dip in stock price despite headwinds in the healthcare sector. With strong sales growth and positive EPS over the past 5 years, investors are watching to see if NVAX can overcome challenges.

COVID Vaccine Prices Announced: Pfizer, Moderna, and Novavax Doses Priced Between $120 and $130

Discover the latest COVID-19 vaccine prices from Pfizer, Moderna, and Novavax. Learn about their effectiveness, eligibility, and impact on public health.

COVID Infections Rise in Canada as Experts Monitor New Variant BA.2.86

Stay informed about the concerning rise in COVID cases in Canada, including the new variant BA.2.86. Vaccinations and precautions are crucial for protection.

Novavax’s Updated COVID-19 Vaccine Shows Immune Response to Emerging Eris Subvariant

Novavax's updated COVID-19 vaccine shows promise in immune response against emerging Eris subvariant. Learn more about its potential impact.

Popular

Novavax to Supply US HHS-Approved Protein-Based XBB COVID Vaccine Globally

Novavax to supply protein-based XBB COVID vaccine as specified in US HHS letter. mRNA-free option for individuals concerned about mRNA-based vaccines.

Canada’s Agreement to Cover Unused Covid Vaccines Boosts Novavax Stock

Novavax shares surge as Canada pays for unused Covid shots, signaling potential turnaround for struggling biotech company. Challenges remain amid competition and legal disputes.

Novavax Stock Plunges 28% in First Half of 2023 as Investors Face Setback

Novavax stock drops 28% in 1H 2023 as COVID-19 vaccine demand declines. Can Novavax regain investor confidence? Find out here.

Novavax’s Updated COVID-19 Vaccine Shows Immune Response to Emerging Eris Subvariant

Novavax's updated COVID-19 vaccine shows promise in immune response against emerging Eris subvariant. Learn more about its potential impact.

Subscribe

spot_imgspot_img